Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × obinutuzumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 42 Lymphoma, Follicular 23 Lymphoma, Non-Hodgkin 17 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma 12 Lymphoma, Mantle-Cell 11 Lymphoma, B-Cell, Marginal Zone 11 Recurrence 8 Lymphoma, B-Cell 7 Neoplasms 6 Burkitt Lymphoma 5 Neoplasm, Residual 3 Leukemia, Hairy Cell 3 Leukemia, B-Cell 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Part1: Advanced B-cell Malignancies 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Mesothelioma 1 Melanoma 1 Mature B-cell Malignancies 1 Lymphoma, T-Cell, Cutaneous 1 Lymphatic Diseases 1 Leukemia, Prolymphocytic 1 Hodgkin Disease 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 Brentuximab Vedotin 4 romidepsin 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡